An integrated ion-exchange membrane-based microfluidic device for irreversible dissociation and quantification of

Kyle P McCarthy1, David B Go1,2, Satyajyoti Senapati1

  • 1Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, USA. hchang@nd.edu.

Lab on a Chip
|December 16, 2022
PubMed

Insights

This study introduces a novel microfluidic assay for quantifying microRNAs bound to ribonucleoproteins (RNPs). The technology enables rapid, direct measurement of RNP-associated RNAs for advanced cancer diagnostics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Background:

  • Ribonucleoproteins (RNPs), including microRNA-induced silencing complex (miRISC), play a role in cancer-related gene regulation.
  • Dysregulation of tumor-suppressing genes by specific RNA-protein complexes is linked to cancer development.
  • Quantifying microRNAs (miRNAs) bound to RNPs is challenging due to high protein-RNA binding affinity.

Purpose of the Study:

  • To develop a microfluidic point-of-care assay for direct quantification of RNP-associated RNAs.
  • To enable advanced RNP profiling for applications like liquid biopsy.
  • To overcome the challenge of high protein-RNA binding affinity in RNP complex analysis.

Main Methods:

  • Development of a microfluidic assay utilizing an integrated cation-anion exchange membrane (CEM/AEM) platform.
  • Application of a high electric field (>100 V cm⁻¹) to induce rapid and irreversible dissociation of RNP complexes (e.g., Cas9-miR-21).
  • Concentration of RNPs at a depletion front for efficient dissociation and subsequent electrophoretic separation of RNA.

Main Results:

  • Achieved rapid and irreversible dissociation of RNP complexes (k = 0.0025 s⁻¹) within 40 minutes.
  • Demonstrated ~100% dissociation of low Kᴅ (∼0.5 nM) complexes despite high association rates (k<0xE2><0x82><0x99> = 6.1 s⁻¹).
  • Established a detection limit of 1.1 nM for Cy3-labeled miR-21, with dissociated RNA driven out of the concentrated zone without reassociation.

Conclusions:

  • The developed microfluidic assay allows direct quantification of RNP-associated RNAs.
  • This technology offers potential for advancing RNP profiling in liquid biopsies for cancer detection.
  • The CEM/AEM platform effectively dissociates stable RNP complexes, facilitating accurate miRNA quantification.